A detailed history of Driehaus Capital Management LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 1,442,207 shares of TMDX stock, worth $111 Million. This represents 2.22% of its overall portfolio holdings.

Number of Shares
1,442,207
Previous 1,486,073 2.95%
Holding current value
$111 Million
Previous $224 Million 1.16%
% of portfolio
2.22%
Previous 2.41%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$135.68 - $176.11 $5.95 Million - $7.73 Million
-43,866 Reduced 2.95%
1,442,207 $226 Million
Q2 2024

Aug 14, 2024

BUY
$72.62 - $150.62 $14.7 Million - $30.6 Million
202,867 Added 15.81%
1,486,073 $224 Million
Q1 2024

May 15, 2024

BUY
$70.86 - $89.93 $13.7 Million - $17.3 Million
192,699 Added 17.67%
1,283,206 $94.9 Million
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $3.29 Million - $7.26 Million
89,595 Added 8.95%
1,090,507 $86.1 Million
Q3 2023

Nov 14, 2023

SELL
$53.47 - $96.07 $8.62 Million - $15.5 Million
-161,302 Reduced 13.88%
1,000,912 $54.8 Million
Q2 2023

Aug 14, 2023

BUY
$66.23 - $88.73 $5.96 Million - $7.99 Million
90,023 Added 8.4%
1,162,214 $97.6 Million
Q1 2023

May 15, 2023

SELL
$53.63 - $82.33 $1.57 Million - $2.4 Million
-29,186 Reduced 2.65%
1,072,191 $81.2 Million
Q4 2022

Feb 14, 2023

BUY
$39.08 - $64.29 $4.1 Million - $6.74 Million
104,808 Added 10.52%
1,101,377 $68 Million
Q3 2022

Nov 14, 2022

BUY
$31.56 - $55.75 $12 Million - $21.3 Million
381,688 Added 62.08%
996,569 $41.6 Million
Q2 2022

Aug 15, 2022

BUY
$20.56 - $32.15 $12.6 Million - $19.8 Million
614,881 New
614,881 $19.3 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.46B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.